Virios Therapeutics, Inc. (NASDAQ:VIRI) Q3 2023 Earnings Call Transcript November 13, 2023
Virios Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.1.
Operator: Good day, and welcome to the Virios Therapeutics, Inc. Third Quarter 2023 Earnings Update. At this time, all participants have been placed on a listen-only mode. Please be advised that today’s call is being recorded at the company’s request. At this time, I’d like to turn the call over to...
